The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study
Open accessAbstract
The development of inhibitory antibodies to factor VIII is a serious complication of hemophilia. FEIBA (factor VIII inhibitor-bypassing activity), an activated prothrombin complex concentrate (aPCC), and NovoSeven, recombinant factor VIIa (rFVIIa), are used as hemostatic bypassing agents in treating patients with inhibitors. The FENOC study was designed to test equivalence of the products in the treatment of ankle, knee, and elbow joint bleeding. A prospective, open-label, randomized, crossover, equivalency design was used. The parameters of interest were the percentage of patients who reported efficacy in response to FEIBA and the percentage that reported efficacy in response to NovoSeven. A difference in these percentages of no more than 15% was determined to be a clinically acceptable magnitude for equivalence of the 2 products. The primary outcome was evaluation 6 hours after treatment. Data for 96 bleeding episodes contributed by 48 participants were analyzed. The criterion for declaring the 2 products equivalent at 6 hours was not met; however, the confidence interval of the difference in percentages of efficacy reported for each product only slightly exceeded the 15% boundary (−11.4%-15.7%), P = .059. FEIBA and NovoSeven appear to exhibit a similar effect on joint bleeds, although the efficacy between products is rated differently by a substantial proportion of patients. This trial was registered at www.clinicaltrials.gov as #NCT00166309.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
The epidemiology of inhibitors in haemophilia A: a systematic review
Wight, J., & Paisley, S. (2003) · Haemophilia · doi:10.1046/j.1365-2516.2003.00780.x · Cited by 627
Aledort, L., Beardsley, D., Cooper, H., Davignon, G., Ewenstein, B., Gilchrist, G., Gill, J., Glader, B., Hoots, W. K., Kisker, C. T., et al. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615388 · Cited by 354
Sjamsoedin, L. J. M., Heijnen, L., Mauser-Bunschoten, E. P., van Geijlswijk, J. L., van Houwelingen, H., van Asten, P., & Sixma, J. J. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109243051301 · Cited by 304
Negrier, C., Goudemand, J., Sultan, Y., Bertrand, M., Rothschild, C., Lauroua, P., & the members of the French FEIBA study group (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656122 · Cited by 276
Clinical experience with recombinant factor VIIa
Lusher, J., Ingerslev, J., Roberts, H., & Hedner, U. (1998) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199803000-00002 · Cited by 215
Turecek, P. L., Váradi, K., Gritsch, H., & Schwarz, H. P. (2004) · Haemophilia · doi:10.1111/j.1365-2516.2004.00934.x · Cited by 172
Lee, M. L., & Lusher, J. M. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100315 · Cited by 21
Cited by
The past and future of haemophilia: diagnosis, treatments, and its complications
Peyvandi, F., Garagiola, I., & Young, G. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01123-x · Cited by 505
Kitazawa, T., Igawa, T., Sampei, Z., Muto, A., Kojima, T., Soeda, T., Yoshihashi, K., Okuyama-Nishida, Y., Saito, H., Tsunoda, H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2942 · Cited by 507
Baudo, F., Collins, P., Huth-Kühne, A., Lévesque, H., Marco, P., Nemes, L., Pellegrini, F., Tengborn, L., & Knoebl, P. (2012) · Blood · doi:10.1182/blood-2012-02-408930 · Cited by 386
Blood Coagulation: Hemostasis and Thrombin Regulation
Tanaka, K. A., Key, N. S., & Levy, J. H. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31819bcc9c · Cited by 342
Berntorp, E., & Shapiro, A. D. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61139-2 · Cited by 335
Self-citation
Metadata
- Authors
- Astermark, J., Donfield, S. M., DiMichele, D. M., Gringeri, A., Gilbert, S. A., Waters, J., Berntorp, E., & for the FENOC Study Group
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2006-09-21
- Volume
- 109
- Issue
- 2
- Pages
- 546-551
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2098951552
- Cited by
- 473
- References
- 8
- FWCI
- 12.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. https://app.cochat.ai/papers/10.1182/blood-2006-04-017988
- The paper
- Astermark, J., Donfield, S. M., DiMichele, D. M., Gringeri, A., Gilbert, S. A., Waters, J., Berntorp, E., & for the FENOC Study Group. (2007). A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood. https://doi.org/10.1182/blood-2006-04-017988
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.